Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 2
2019 3
2020 1
2021 4
2023 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Predicting 2-year all-cause mortality after contemporary PCI: Updating the logistic clinical SYNTAX score.
Chichareon P, van Klaveren D, Modolo R, Kogame N, Takahashi K, Chang CC, Tomaniak M, Yuan J, Xie L, Song Y, Qiao S, Yang Y, Guan C, Zurakowski A, van Geuns RJ, Sabate M, Ong PJ, Wykrzykowska JJ, Piek JJ, Garg S, Hamm C, Steg G, Vranckx P, Valgimigli M, Windecker S, Juni P, Onuma Y, Steyerberg E, Xu B, Serruys PW. Chichareon P, et al. Catheter Cardiovasc Interv. 2021 Dec 1;98(7):1287-1297. doi: 10.1002/ccd.29490. Epub 2021 Feb 4. Catheter Cardiovasc Interv. 2021. PMID: 33539048
Final five-year results of the REMEDEE Registry: Real-world experience with the dual-therapy COMBO stent.
Kerkmeijer LSM, Chandrasekhar J, Kalkman DN, Woudstra P, Menown IBA, Suryapranata H, den Heijer P, Iñiguez A, van 't Hof AWJ, Erglis A, Arkenbout KE, Muller P, Koch KT, Tijssen JG, Beijk MAM, de Winter RJ. Kerkmeijer LSM, et al. Catheter Cardiovasc Interv. 2021 Sep;98(3):503-510. doi: 10.1002/ccd.29305. Epub 2020 Oct 8. Catheter Cardiovasc Interv. 2021. PMID: 33029937 Free PMC article.
'Ticagrelor alone vs. dual antiplatelet therapy from 1 month after drug-eluting coronary stenting among patients with STEMI': a post hoc analysis of the randomized GLOBAL LEADERS trial.
Gamal AS, Hara H, Tomaniak M, Lunardi M, Gao C, Ono M, Kawashima H, Jüni P, Vranckx P, Windecker S, Hamm C, Steg PG, Onuma Y, Serruys PW. Gamal AS, et al. Eur Heart J Acute Cardiovasc Care. 2021 Oct 1;10(7):756-773. doi: 10.1093/ehjacc/zuab033. Eur Heart J Acute Cardiovasc Care. 2021. PMID: 34212187 Free PMC article. Clinical Trial.
Predictive factors of discordance between the instantaneous wave-free ratio and fractional flow reserve.
Dérimay F, Johnson NP, Zimmermann FM, Adjedj J, Witt N, Hennigan B, Koo BK, Barbato E, Esposito G, Trimarco B, Rioufol G, Park SJ, Baptista SB, Chrysant GS, Leone AM, Jeremias A, Berry C, De Bruyne B, Oldroyd KG, Pijls NHJ, Fearon WF. Dérimay F, et al. Catheter Cardiovasc Interv. 2019 Sep 1;94(3):356-363. doi: 10.1002/ccd.28116. Epub 2019 Jan 31. Catheter Cardiovasc Interv. 2019. PMID: 30702186
Global guidelines and initiatives from the European Confederation of Medical Mycology to improve patient care and research worldwide: New leadership is about working together.
Hoenigl M, Gangneux JP, Segal E, Alanio A, Chakrabarti A, Chen SC, Govender N, Hagen F, Klimko N, Meis JF, Pasqualotto AC, Seidel D, Walsh TJ, Lagrou K, Lass-Flörl C, Cornely OA; European Confederation of Medical Mycology (ECMM). Hoenigl M, et al. Mycoses. 2018 Nov;61(11):885-894. doi: 10.1111/myc.12836. Epub 2018 Aug 28. Mycoses. 2018. PMID: 30086186
Acute kidney injury in patients with acute coronary syndrome undergoing invasive management treated with bivalirudin vs. unfractionated heparin: insights from the MATRIX trial.
Landi A, Branca M, Andò G, Russo F, Frigoli E, Gargiulo G, Briguori C, Vranckx P, Leonardi S, Gragnano F, Calabrò P, Campo G, Ambrosio G, Santucci A, Varbella F, Zaro T, Heg D, Windecker S, Jüni P, Pedrazzini G, Valgimigli M; MATRIX Investigators. Landi A, et al. Eur Heart J Acute Cardiovasc Care. 2021 Dec 18;10(10):1170-1179. doi: 10.1093/ehjacc/zuab080. Eur Heart J Acute Cardiovasc Care. 2021. PMID: 34491323 Clinical Trial.
Impact of percutaneous closure device type on vascular and bleeding complications after TAVR: A post hoc analysis from the BRAVO-3 randomized trial.
Power D, Schäfer U, Guedeney P, Claessen BE, Sartori S, Sorrentino S, Lefèvre T, Kupatt C, Tchetche D, Dumonteil N, Webb JG, Colombo A, Windecker S, Ten Berg JM, Hildick-Smith D, Boekstegers P, Linke A, Tron C, Van Belle E, Asgar AW, Jeger R, Sardella G, Hink U, Husser O, Grube E, Lechthaler I, Wijngaard P, Anthopoulos P, Deliargyris EN, Bernstein D, Hengstenberg C, Mehran R, Dangas GD. Power D, et al. Catheter Cardiovasc Interv. 2019 Jun 1;93(7):1374-1381. doi: 10.1002/ccd.28295. Epub 2019 May 22. Catheter Cardiovasc Interv. 2019. PMID: 31116908